PATENT CLAIM ANALYSIS

Application Number: 15913086
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "489000"]

Abstract:
The object of the present invention is an injectable sterile aqueous formulation, ready-to-use, resorbable, used for aesthetic purposes as a particulate, cohesive, viscoelastic gel comprising i) crosslinked hyaluronic acid, or one of its salts, at a concentration of between 1% and 4% (mass/volume); the crosslinking carried out providing the possibility of obtaining a gel based on crosslinked hyaluronic acid with a so-called cohesive structure, and ii) hydroxyapatite, at a concentration of between 5% and 60% (mass/volume), said hydroxyapatite being in the form of particles with an average size of less than or equal to 200 μm; said injectable sterile aqueous formulation having viscoelastic properties such that tan δ at the frequency of 1 Hz is less than or equal to 0.60.

Claim (Index 16):
The kit of  claim 15 , wherein the injectable sterile aqueous formulation is comprised in a syringe, an ampoule or a flask.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.73494
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15356885', '14896504', '15129876', '15526460', '13653266']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7540357093351745
- 35 USC 102 Novelty (BERT): 0.5627628688592364
- Combined Prediction Score: 0.7349084252875807
- Mean Citation Score: 294.05315
- Max Citation Score: 456.69186
- Similarity Product: 317.9917519482243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test